Agios Pharmaceuticals
AGIO
#5058
Rank
$1.86 B
Marketcap
$31.25
Share price
-1.73%
Change (1 day)
-23.58%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2026 (TTM): -$0.46 Billion USD

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are $98.33 Million USD. In 2025 the company made an earning of -$0.48 Billion USD a decrease over its 2024 earnings that were of -$0.43 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$0.46 Billion-2.78%
2025 -$0.48 Billion10.9%
2024 -$0.43 Billion8.75%
2023 -$0.4 Billion0.63%
2022 -$0.39 Billion2.81%
2021 -$0.38 Billion10.58%
2020 -$0.35 Billion-18.41%
2019 -$0.42 Billion15.72%
2018 -$0.37 Billion12.99%
2017 -$0.33 Billion59.61%
2016 -$0.21 Billion69.32%
2015 -$0.12 Billion119.28%
2014 -$54.14 Million39.22%
2013 -$38.89 Million69.1%
2012 -$23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$6.90 B-1,604.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$33.59 B-7,418.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$7.88 B-1,818.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-$0.17 Billion-64.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
$1.03 B-325.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.14 B-132.48%๐Ÿ‡บ๐Ÿ‡ธ USA